KIF1B promotes glioma migration and invasion via cell surface localization of MT1-MMP

Oncology Reports

Volumn 35, Issue 2, 2016, Pages 971-977

  Chen, Songyu ^a,b,c   Han, Mingzhi ^a,c   Chen, Weiliang ^a,c   He, Ying ^a,c   Huang, Bin ^a,c   Zhao, Peng ^a,c   Huang, Qibing ^a,c   Gao, Liang ^b   Qu, Xun ^a   Li, Xingang ^a,c  

^a SHANDONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Glioma; KIF1B; Neoplasm invasiveness membrane type 1 matrix metalloproteinase; Pathology

Indexed keywords

KINESIN; KINESIN FAMILY MEMBER 1B; MATRIX METALLOPROTEINASE 14; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; KIF1B PROTEIN, HUMAN; TUMOR PROTEIN;

A172 CELL LINE; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER TISSUE; CELL INVASION; CELL LYSATE; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; U87MG CELL LINE; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION; ANTAGONISTS AND INHIBITORS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL MEMBRANE; CELL MOTION; ENZYME INDUCTION; ENZYMOLOGY; GENETIC DATABASE; GENETIC TRANSFECTION; GENETICS; GLIOMA; METABOLISM; MORTALITY; OLIGODENDROGLIOMA; PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION;

ASTROCYTOMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; DATABASES, GENETIC; DOWN-REGULATION; ENZYME INDUCTION; GLIOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; KINESIN; MATRIX METALLOPROTEINASE 14; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGODENDROGLIOMA; PROGNOSIS; PROTEIN TRANSPORT; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84954286175     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4426     Document Type: Article

References (30)

1. Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med 359: 492-507, 2008.
2. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al: Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007.
3. Lucio-Eterovic AK, Piao Y and de Groot JF: Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy. Clin Cancer Res 15: 4589-4599, 2009.
4. Poincloux R, Lizárraga F and Chavrier P: Matrix invasion by tumour cells: A focus on MT1-MMP trafficking to invadopodia. J Cell Sci 122: 3015-3024, 2009.
5. Fillmore HL, VanMeter TE and Broaddus WC: Membrane-type matrix metalloproteinases (MT-MMPs): Expression and function during glioma invasion. J Neurooncol 53: 187-202, 2001.
6. Guo P, Imanishi Y, Cackowski FC, Jarzynka MJ, Tao HQ, Nishikawa R, Hirose T, Hu B and Cheng SY: Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol 166: 877-890, 2005.
7. Wang L, Yuan J, Tu Y, Mao X, He S, Fu G, Zong J and Zhang Y: Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma. Clin Transl Oncol 15: 139-145, 2013.
8. Rath O and Kozielski F: Kinesins and cancer. Nat Rev Cancer 12: 527-539, 2012.
9. Wang CQ, Qu X, Zhang XY, Zhou CJ, Liu GX, Dong ZQ, Wei FC and Sun SZ: Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue. Oral Oncol 46: 65-69, 2010.
10. Wang J, Ma S, Ma R, Qu X, Liu W, Lv C, Zhao S and Gong Y: KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in in breast cancer. BMC cancer 14: 461, 2014.
11. Liu Z, Rebowe RE, Wang Z, Li Y, Wang Z, DePaolo JS, Guo J, Qian C and Liu W: KIF3a promotes proliferation and invasion via Wnt signaling in advanced prostate cancer. Mol Cancer Res 12: 491-503, 2014.
12. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Yamazaki H and Hirokawa N: KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79: 1209-1220, 1994.
13. Lyons DA, Naylor SG, Scholze A and Talbot WS: Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons. Nat Genet 41: 854-858, 2009.
14. Z hao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, et al: Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105: 587-597, 2001.
15. Dong Z, Xu X, Du L, Yang Y, Cheng H, Zhang X, Li Z, Wang L, Li J, Liu H, et al: Leptin-mediated regulation of MT1-MMP localization is KIF1B dependent and enhances gastric cancer cell invasion. Carcinogenesis 34: 974-983, 2013.
16. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007.
17. Yang YM, Feng AL, Zhou CJ, Liang XH, Mao HT, Deng BP, Yan S, Sun JT, Du LT, Liu J, et al: Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppression. Cancer Sci 102: 1264-1271, 2011.
18. Z hao P, Li XG, Yang M, Shao Q, Wang D, Liu S, Song H, Song B, Zhang Y and Qu X: Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol Immunol 45: 2187-2195, 2008.
19. Wang W, Sima N, Kong D, Luo A, Gao Q, Liao S, Li W, Han L, Wang J, Wang S, et al: Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo. Cancer Lett 291: 67-75, 2010.
20. Liu Q, Li G, Li R, Shen J, He Q, Deng L, Zhang C and Zhang J: IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol 100: 165-176, 2010.
21. Palfi S, Swanson KR, De Boüard S, Chrétien F, Oliveira R, Gherardi RK, Kros JM, Peschanski M and Christov C: Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer 91: 745-752, 2004.
22. Bie L, Zhao G, Wang YP and Zhang B: Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas. Clin Neurol Neurosurg 114: 356-360, 2012.
23. Wang Q, Wang L, Li D, Deng J, Zhao Z, He S, Zhang Y and Tu Y: Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients. Cancer Epidemiol 37: 79-84, 2013.
24. Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, Inagawa K, Kawakami Y, Yoshida K and Toda M: Downregulation of KIF23 suppresses glioma proliferation. J Neurooncol 106: 519-529, 2012.
25. Ulasov I, Yi R, Guo D, Sarvaiya P and Cobbs C: The emerging role of MMP14 in brain tumorigenesis and future therapeutics. Biochim Biophys Acta 1846: 113-120, 2014.
26. Annabi B, Laflamme C, Sina A, Lachambre MP and Béliveau R: A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells. J Neuroinflammation 6: 8, 2009.
27. Hardee ME and Zagzag D: Mechanisms of glioma-associated neovascularization. Am J Pathol 181: 1126-1141, 2012.
28. Deryugina EI, Soroceanu L and Strongin AY: Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 62: 580-588, 2002.
29. Akita H, Kogure K, Moriguchi R, Nakamura Y, Higashi T, Nakamura T, Serada S, Fujimoto M, Naka T, Futaki S, et al: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. J Control Release 143: 311-317, 2010.
30. Yagi N, Manabe I, Tottori T, Ishihara A, Ogata F, Kim JH, Nishimura S, Fujiu K, Oishi Y, Itaka K, et al: A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo. Cancer Res 69: 6531-6538, 2009.